Dr. Raza Bokhari, Executive Chairman & CEO of Medicus will deliver a company presentation as Medicus enters 2026 with multiple Phase 2 Catalysts across clinical, regulatory, and pipeline expansion ...
The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...
CES 2026 ? The Video Electronics Standards Association (VESA®) today announced the release of version 1.1 of its DisplayPorttm Automotive Extension (DP AE) specification?the first open industry ...
HotCopper on MSN
'Much greater understanding': Olympio booms +70% on juicy final assays from Bousquet drilling
Gold explorer Olympio Metals (ASX:OLY) has boomed as much as +70% through Tuesday morning’s trade after unveiling some ...
22h
No. 1 Indiana starts post-Mendoza era by adding former TCU quarterback, new receiver, AP source says
As No. 1 Indiana prepares for Friday night's College Football Playoff semifinal against No. 5 Oregon, coach Curt Cignetti is ...
Enveda Biosciences was recently cleared to begin clinical trials of its drug candidate for the treatment of inflammatory bowel disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback